原发性肝癌放射治疗专家共识(2020年版)

2020-10-30 中国医师协会肝癌专业委员会 临床肿瘤学杂志.2020.25(10):935-946.

原发性肝癌是我国发病率较高的恶性肿瘤之一,据报道,2015 年我国原发性肝癌新发患者46. 6 万例,死亡42. 2 万例,超过世界原发性肝癌发病总例数的一半。为此,许多肝癌治疗相关学会都制订了原发性

中文标题:

原发性肝癌放射治疗专家共识(2020年版)

发布日期:

2020-10-30

简要介绍:

原发性肝癌是我国发病率较高的恶性肿瘤之一,据报道,2015 年我国原发性肝癌新发患者46. 6 万例,死亡42. 2 万例,超过世界原发性肝癌发病总例数的一半。为此,许多肝癌治疗相关学会都制订了原发性肝癌( 主要是肝细胞肝癌) 的诊治指南、共识或规范。原发性肝癌放射治疗已经得到这些学会的认可,并写入指南、共识或规范。本学组在2016 年组织撰写了《2016年原发性肝癌放射治疗共识》,作为国内首部原发性肝癌放疗相关的共识,受到业内的高度重视和好评,有效地规范了原发性肝癌的放疗。此次根据临床实际情况,结合近年来肝癌放疗的最新研究进展,尤其是随机对照的高循证级别的研究,在2016 年版的基础上进行了更新。

相关资料下载:
[AttachmentFileName(sort=1, fileName=原发性肝癌放射治疗专家共识_2020年版_曾昭冲.pdf)] GetToolGuiderByIdResponse(projectId=1, id=9b8021c0020255ba, title=原发性肝癌放射治疗专家共识(2020年版), enTitle=, guiderFrom=临床肿瘤学杂志.2020.25(10):935-946., authorId=0, author=, summary=原发性肝癌是我国发病率较高的恶性肿瘤之一,据报道,2015 年我国原发性肝癌新发患者46. 6 万例,死亡42. 2 万例,超过世界原发性肝癌发病总例数的一半。为此,许多肝癌治疗相关学会都制订了原发性, cover=https://img.medsci.cn/20201219/1608311330888_2020535.jpg, journalId=0, articlesId=null, associationId=1774, associationName=中国医师协会肝癌专业委员会, associationIntro=, copyright=0, guiderPublishedTime=Fri Oct 30 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>原发性肝癌是我国发病率较高的恶性肿瘤之一,据报道,2015 年我国原发性肝癌新发患者46. 6 万例,死亡42. 2 万例,超过世界原发性肝癌发病总例数的一半。为此,许多肝癌治疗相关学会都制订了原发性肝癌( 主要是肝细胞肝癌) 的诊治指南、共识或规范。原发性肝癌放射治疗已经得到这些学会的认可,并写入指南、共识或规范。本学组在2016 年组织撰写了《2016年原发性肝癌放射治疗共识》,作为国内首部原发性肝癌放疗相关的共识,受到业内的高度重视和好评,有效地规范了原发性肝癌的放疗。此次根据临床实际情况,结合近年来肝癌放疗的最新研究进展,尤其是随机对照的高循证级别的研究,在2016 年版的基础上进行了更新。</p> </div> </div> </div>, tagList=[TagDto(tagId=1097, tagName=原发性肝癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=22, categoryName=肝病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1097, guiderKeyword=原发性肝癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3428, appHits=189, showAppHits=0, pcHits=826, showPcHits=3239, likes=0, shares=9, comments=5, approvalStatus=1, publishedTime=Sat Dec 19 01:18:29 CST 2020, publishedTimeString=2020-10-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat Dec 19 01:08:56 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 03:33:03 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=原发性肝癌放射治疗专家共识_2020年版_曾昭冲.pdf)])
原发性肝癌放射治疗专家共识_2020年版_曾昭冲.pdf
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1195348, encodeId=aee0119534812, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6155204120, createdName=14746382m89暂无昵称, createdTime=Sun Feb 20 14:55:32 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195347, encodeId=606a119534e57, content=该文章分享了各位专家对原发性肝癌放疗的共识,为临床工作分享了自己的见解和目前最新研究结果,具有指导作用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6155204120, createdName=14746382m89暂无昵称, createdTime=Sun Feb 20 14:54:51 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001058, encodeId=f0d510010588b, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJmSeSJiaIXeRnYgcyew07sbvm8Ru4WQvenVM67kB4c3XqQiapI7RLuricFhDhibONNicj5mnfQ4TeBqhg/132, createdBy=99222125332, createdName=isozhyy, createdTime=Tue Jul 20 09:43:08 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955552, encodeId=0a299555522e, content=非常好,下载学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80ca5478750, createdName=肥冬, createdTime=Fri Apr 09 18:55:19 CST 2021, time=2021-04-09, status=1, ipAttribution=)]
    2022-02-20 14746382m89暂无昵称

    谢谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1195348, encodeId=aee0119534812, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6155204120, createdName=14746382m89暂无昵称, createdTime=Sun Feb 20 14:55:32 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195347, encodeId=606a119534e57, content=该文章分享了各位专家对原发性肝癌放疗的共识,为临床工作分享了自己的见解和目前最新研究结果,具有指导作用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6155204120, createdName=14746382m89暂无昵称, createdTime=Sun Feb 20 14:54:51 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001058, encodeId=f0d510010588b, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJmSeSJiaIXeRnYgcyew07sbvm8Ru4WQvenVM67kB4c3XqQiapI7RLuricFhDhibONNicj5mnfQ4TeBqhg/132, createdBy=99222125332, createdName=isozhyy, createdTime=Tue Jul 20 09:43:08 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955552, encodeId=0a299555522e, content=非常好,下载学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80ca5478750, createdName=肥冬, createdTime=Fri Apr 09 18:55:19 CST 2021, time=2021-04-09, status=1, ipAttribution=)]
    2022-02-20 14746382m89暂无昵称

    该文章分享了各位专家对原发性肝癌放疗的共识,为临床工作分享了自己的见解和目前最新研究结果,具有指导作用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1195348, encodeId=aee0119534812, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6155204120, createdName=14746382m89暂无昵称, createdTime=Sun Feb 20 14:55:32 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195347, encodeId=606a119534e57, content=该文章分享了各位专家对原发性肝癌放疗的共识,为临床工作分享了自己的见解和目前最新研究结果,具有指导作用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6155204120, createdName=14746382m89暂无昵称, createdTime=Sun Feb 20 14:54:51 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001058, encodeId=f0d510010588b, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJmSeSJiaIXeRnYgcyew07sbvm8Ru4WQvenVM67kB4c3XqQiapI7RLuricFhDhibONNicj5mnfQ4TeBqhg/132, createdBy=99222125332, createdName=isozhyy, createdTime=Tue Jul 20 09:43:08 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955552, encodeId=0a299555522e, content=非常好,下载学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80ca5478750, createdName=肥冬, createdTime=Fri Apr 09 18:55:19 CST 2021, time=2021-04-09, status=1, ipAttribution=)]
    2021-07-20 isozhyy

    谢谢

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1195348, encodeId=aee0119534812, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6155204120, createdName=14746382m89暂无昵称, createdTime=Sun Feb 20 14:55:32 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195347, encodeId=606a119534e57, content=该文章分享了各位专家对原发性肝癌放疗的共识,为临床工作分享了自己的见解和目前最新研究结果,具有指导作用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6155204120, createdName=14746382m89暂无昵称, createdTime=Sun Feb 20 14:54:51 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001058, encodeId=f0d510010588b, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJmSeSJiaIXeRnYgcyew07sbvm8Ru4WQvenVM67kB4c3XqQiapI7RLuricFhDhibONNicj5mnfQ4TeBqhg/132, createdBy=99222125332, createdName=isozhyy, createdTime=Tue Jul 20 09:43:08 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955552, encodeId=0a299555522e, content=非常好,下载学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80ca5478750, createdName=肥冬, createdTime=Fri Apr 09 18:55:19 CST 2021, time=2021-04-09, status=1, ipAttribution=)]
    2021-04-09 肥冬

    非常好,下载学习

    0